Duopharma Biotech Berhad (hereinafter referred to as the “Company”) is pleased to announce that as at to date –

1. Duopharma (M) Sendirian Berhad (“DMSB”) (a wholly-owned subsidiary of the Company) has received and accepted seven (7) Letters of Offer (“LOO”); and

2. Duopharma Manufacturing (Bangi) Sdn. Bhd. (“DMfgB”) (a wholly-owned subsidiary of the Company) has received and accepted four (4) LOOs,

from Pharmaniaga Logistics Sdn. Bhd. (hereinafter referred to as the “Customer”) for the supply of pharmaceutical and/or non-pharmaceutical products as set out in the respective LOOs (hereinafter referred to as “Products”) to the offices and facilities operated and controlled by the Government of Malaysia, through the Customer (hereinafter referred to as the “Contract(s)”). All the Contract(s) shall remain valid and binding until 31 December 2026 or such other date as directed by the Government of Malaysia. The total number of Products in aggregate to be supplied under all the aforementioned Contract(s) is 86 and the total estimated value in aggregate of all the aforementioned Contract(s) is approximately RM578,093,475.72 for the duration of the Contract(s).

The acceptance of the Contract(s) from Pharmaniaga Logistics Sdn Bhd for the supply of the Products is in the ordinary course of business of the Company.

The full details of the announcement is as per the attached file.

This announcement is dated 30 April 2024.